content

FDA should withdraw ANDAs’,and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly

CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th-7th November 2019) –has released the first part of its eponymous2019 Annual...

Shionogi and Hsiri to develop mycobacterial disease therapies

Japanese pharmaceutical firm Shionogi has signed a licence agreement with Hsiri Therapeutics for the discovery and development of therapies for non-tuberculous mycobacterial (NTM) diseases,...

TriPharm Services announces creation of pharmaceutical manufacturing center

TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utilizing the latest isolator manufacturing equipment. The center...

Biocartis NV.: Biocartis Launches Liquid Biopsy Idylla ctEGFR Mutation Assay

Biocartis Group NV, an innovative molecular diagnostics company announces the launch of the Idylla ctEGFR Mutation Assay (RUO1). This assay is the liquid biopsy...

The growing world of pharmaceutical supply chain

Pharma and Air Cargo- A match climbing-up the ladder One of the most important developments that took place ever in the invention space was indeed...

German pharma benefiting from a Brexit boost?

Research conducted by CPhI Worldwide, the world’s largest pharmaceutical event (organised by Informa Markets and held at Messe Frankfurt, November 5-7), ranks Germany as...

FlyPharma Europe 2019 – Latest supply chain challenges and industry best practices

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices,putting...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read